Wen-xin ZHAO
Fuzhou, Fujian, 350001, China
NCT Number: NCT03172312
Ready to establish the Intraoperative Parathyroid Scores System (IPSS) for thyroidectomy and study the clinical value of Intraoperative Parathyroid Scores System for thyroidectomy.
Looking for future studies?
Notify MeUp to 60 year
All sexes
Observational
Fuzhou, Fujian, 350001, China
IPSS includes transplantation Parathyroid Scores and in situ Parathyroid Scores, the investigators will establish the Intraoperative Parathyroid Scores System by parathyroid size and Blood supply, and recording IPSS, according to certain rules. Parathyroid hormone and calcium were test in d0, d1, d14, d60 post operation. The correlation between Intraoperative Parathyroid Scores and PTH calcium were calculated, and ROC curve and logistic regression were tested for the prediction value.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observe and record parathyroid status during thyroid surgery
Time frame: 2014-2016
relation with transplantation Parathyroid Scores and transplanted parathyroid hormone
Time frame: 2014-2016
relation with Intraoperative Parathyroid Scores and in situ Parathyroid Scores
Time frame: 2014-2016
IPSS and in suit PSS be recoded and D1,D14 PTH Ca2+ were tested
Time frame: 2014-2016
IPSS and in suit PSS be recoded and D1,D14 PTH Ca2+ were tested
Time frame: 2014-2016
description the clinic value
Fujian Medical University
Other
Acronym: IPSS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05022667
Endocrine Gland Neoplasms, Endocrine System Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT05684029
Endocrine Gland Neoplasms, Endocrine System Diseases
Fuzhou, Fujian, China
View Trial DetailsNCT03969108
Autoimmune Diseases, Endocrine Gland Neoplasms
Toronto, Ontario, Canada
View Trial DetailsNCT07428057
Calcium Metabolism Disorders, Endocrine Gland Neoplasms
Minya, Minya Governorate, Egypt
View Trial Details